Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

gallium Ga 68-NOTA-MAL-Cys39-exendin-4

A radiopharmaceutical tracer composed of the glucagon-like peptide-1 receptor (GLP-1R) agonist exendin-4 in which the serine residues (ser39) are replaced with cysteine (cys39) linked by the macrocyclic chelating agent 1,4,7-triazacyclononane-N,N',N''-triacetic acid (NOTA), which is linked to maleimide (MAL), to the positron-emitting radionuclide gallium Ga 68, with potential use in diagnostic imaging upon positron emission tomography (PET)/computed tomography (CT). Upon administration of gallium Ga 68-NOTA-MAL-Cys39-exendin-4, the exendin-4 moiety binds to GLP-1R. The radionuclide moiety can be detected using PET/CT and GLP-1R-expressing tumors can be localized and visualized. GLP-1R, which is located on beta cells and regulates insulin secretion, is overexpressed on insulinomas, which are insulin-secreting neuroendocrine tumors (NETs).
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:68 Ga-NOTA-MAL-Cys39-exendin-4
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search